The Federal University of Espírito Santo is a federal university with headquarters in the city of Vitória, capital of Espírito Santo state, in Brazil. It is the largest and most important university in the state of Espírito Santo, southeastern Brazil.

During the past decade, Federal University of Espirito Santo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Federal University of Espirito Santo" #1 collaborator was "University of Göttingen" with 3 trials as a collaborator, "Centro de Pesquisas René Rachou" with 2 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 2 trials as a collaborator, "Harvard Medical School (HMS and HSDM)" with 2 trials as a collaborator and "Escola Nacional de Saúde Pública Sérgio Arouca/Fiocruz" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Federal University of Espirito Santo" are "Executive Dysfunction" (3 trials), "Drug Addiction" (2 trials), "Abnormal Craving for Drugs" (1 trials), "Acute Kidney Injury" (1 trials) and "Alcohol Dependence" (1 trials). Many other conditions were trialed in "Federal University of Espirito Santo" in a lesser frequency.

Most popular intervention types in "Federal University of Espirito Santo" are "Device" (4 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "transcranial Direct Current Stimulation" (3 trials), "Aerobic exercise with cycle ergometer" (1 trials), "BNP, SAAG, ascites total protein, echocardiography" (1 trials), "ChAdOx1 nCoV-19 vaccine (AZD1222)" (1 trials) and "Half dose of ChAdOx1 nCoV-19 (AZD1222)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Federal University of Espirito Santo" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Federal University of Espirito Santo". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Federal University of Espirito Santo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Federal University of Espirito Santo, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".